Literature DB >> 23375831

In vivo and in vitro investigations of heterozygous nebulin knock-out mice disclose a mild skeletal muscle phenotype.

C Gineste1, J M De Winter, C Kohl, C C Witt, B Giannesini, K Brohm, Y Le Fur, N Gretz, C Vilmen, E Pecchi, M Jubeau, P J Cozzone, G J M Stienen, H Granzier, S Labeit, C A C Ottenheijm, D Bendahan, J Gondin.   

Abstract

Nemaline myopathy is the most common congenital skeletal muscle disease, and mutations in the nebulin gene account for 50% of all cases. Recent studies suggest that the disease severity might be related to the nebulin expression levels. Considering that mutations in the nebulin gene are typically recessive, one would expect that a single functional nebulin allele would maintain nebulin protein expression which would result in preserved skeletal muscle function. We investigated skeletal muscle function of heterozygous nebulin knock-out (i.e., nebulin(+/-)) mice using a multidisciplinary approach including protein and gene expression analysis and combined in vivo and in vitro force measurements. Skeletal muscle anatomy and energy metabolism were studied strictly non-invasively using magnetic resonance imaging and 31P-magnetic resonance spectroscopy. Maximal force production was reduced by around 16% in isolated muscle of nebulin(+/-) mice while in vivo force generating capacity was preserved. Muscle weakness was associated with a shift toward a slower proteomic phenotype, but was not related to nebulin protein deficiency or to an impaired energy metabolism. Further studies would be warranted in order to determine the mechanisms leading to a mild skeletal muscle phenotype resulting from the expression of a single nebulin allele.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375831     DOI: 10.1016/j.nmd.2012.12.011

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

Review 1.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

2.  Comparison of skeletal muscle miRNA and mRNA profiles among three pig breeds.

Authors:  Xinhua Hou; Yalan Yang; Shiyun Zhu; Chaoju Hua; Rong Zhou; Yulian Mu; Zhonglin Tang; Kui Li
Journal:  Mol Genet Genomics       Date:  2015-10-12       Impact factor: 3.291

3.  Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy mice.

Authors:  Josine M de Winter; Charlotte Gineste; Elisa Minardi; Lorenza Brocca; Maira Rossi; Tamara Borsboom; Alan H Beggs; Monique Bernard; David Bendahan; Darren T Hwee; Fady I Malik; Maria Antonietta Pellegrino; Roberto Bottinelli; Julien Gondin; Coen A C Ottenheijm
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 6.150

4.  Alterations at the cross-bridge level are associated with a paradoxical gain of muscle function in vivo in a mouse model of nemaline myopathy.

Authors:  Charlotte Gineste; Coen Ottenheijm; Yann Le Fur; Sébastien Banzet; Emilie Pecchi; Christophe Vilmen; Patrick J Cozzone; Nathalie Koulmann; Edna C Hardeman; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  Synergistic and antagonistic interplay between myostatin gene expression and physical activity levels on gene expression patterns in triceps Brachii muscles of C57/BL6 mice.

Authors:  Kelsey Caetano-Anollés; Sanjibita Mishra; Sandra L Rodriguez-Zas
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

6.  An Engineered Mouse to Identify Proliferating Cells and Their Derivatives.

Authors:  Jihyun Jang; Kurt A Engleka; Feiyan Liu; Li Li; Guang Song; Jonathan A Epstein; Deqiang Li
Journal:  Front Cell Dev Biol       Date:  2020-05-25

Review 7.  Nemaline myopathies: a current view.

Authors:  Caroline A Sewry; Jenni M Laitila; Carina Wallgren-Pettersson
Journal:  J Muscle Res Cell Motil       Date:  2019-06-21       Impact factor: 2.698

8.  Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.

Authors:  Charlotte Gineste; Yann Le Fur; Christophe Vilmen; Arnaud Le Troter; Emilie Pecchi; Patrick J Cozzone; Edna C Hardeman; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.

Authors:  Charlotte Gineste; Guillaume Duhamel; Yann Le Fur; Christophe Vilmen; Patrick J Cozzone; Kristen J Nowak; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  Nebulin nemaline myopathy recapitulated in a compound heterozygous mouse model with both a missense and a nonsense mutation in Neb.

Authors:  Jenni M Laitila; Elyshia L McNamara; Catherine D Wingate; Hayley Goullee; Jacob A Ross; Rhonda L Taylor; Robbert van der Pijl; Lisa M Griffiths; Rachel Harries; Gianina Ravenscroft; Joshua S Clayton; Caroline Sewry; Michael W Lawlor; Coen A C Ottenheijm; Anthony J Bakker; Julien Ochala; Nigel G Laing; Carina Wallgren-Pettersson; Katarina Pelin; Kristen J Nowak
Journal:  Acta Neuropathol Commun       Date:  2020-02-17       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.